nach oben

International Urology and Nephrology

Erschienen in:

03.05.2019 | Urology - Review

Phytotherapy and physical therapy in the management of chronic prostatitis–chronic pelvic pain syndrome

verfasst von: Min Hu, Junaid Wazir, Rahat Ullah, Wenlu Wang, Xingxing Cui, Meng Tang, Xiaohui Zhou

Erschienen in: International Urology and Nephrology | Ausgabe 7/2019

Einloggen, um Zugang zu erhalten

Abstract

Chronic prostatitis (CP)/chronic pelvic pain syndrome (CPPS) is one of the four category prostatitis, and the prevalence is over 90–95% in prostatitis. Because of its pain and obstructive voiding difficulties, it severely affects the quality of life of the patient. However, the standard treatment is still unclear. Given the lack of proven efficacy of conventional therapies (such as antibiotics, anti-inflammatory medications, and alpha-blockers), many patients have turned to phytotherapy and other alternative treatments. In recent years, phytotherapy and physical therapy have advanced a lot because of the safety, efficacy and high compliance. This review covers phytotherapy (quercetin, bee pollen, pumpkin seed oil, eviprostat, terpene mixture) and physical therapy (acupuncture, shock wave, thermobalancing, transurethral needle ablation, transcutaneous electrical nerve stimulation sono-electro-magnetic therapy) commonly used in chronic prostatitis to help the clinician and researchers.

Khan FU, Ihsan AU, Khan HU, Jana R, Wazir J, Khongorzul P, Waqar M, Zhou X (2017) Comprehensive overview of prostatitis. Biomed Pharmacother 94:1064–1076CrossRef

Franco JV, Turk T, Jung JH, Xiao YT, Iakhno S, Garrote V, Vietto V (2018) Non‐pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome: a Cochrane systematic review. BJU Int. https://doi.org/10.1111/bju.14492 CrossRefPubMed

Mo MQ, Long LL, Xie WL, Chen S, Zhang WH, Luo CQ, Deng LW (2014) Sexual dysfunctions and psychological disorders associated with type IIIa chronic prostatitis: a clinical survey in China. Int Urol Nephrol 46(12):2255–2261. https://doi.org/10.1007/s11255-014-0810-2 CrossRefPubMed

Pontari MA (2007) Etiologic theories of chronic prostatitis/chronic pelvic pain syndrome. Curr Urol Rep 8(4):307–312CrossRef

Westesson KE, Shoskes DA (2010) Chronic prostatitis/chronic pelvic pain syndrome and pelvic floor spasm: can we diagnose and treat? Curr Urol Rep 11(4):261–264. https://doi.org/10.1007/s11934-010-0111-y CrossRefPubMed

Herati AS, Moldwin RM (2013) Alternative therapies in the management of chronic prostatitis/chronic pelvic pain syndrome. World J Urol 31(4):761–766. https://doi.org/10.1007/s00345-013-1097-0 CrossRefPubMed

Kurita M, Yamaguchi H, Okamoto K, Kotera T, Oka M (2018) Chronic pelvic pain and prostate inflammation in rat experimental autoimmune prostatitis: effect of a single treatment with phosphodiesterase 5 inhibitors on chronic pelvic pain. Prostate 78(15):1157–1165. https://doi.org/10.1002/pros.23690 CrossRefPubMed

Polackwich A, Shoskes D (2016) Chronic prostatitis/chronic pelvic pain syndrome: a review of evaluation and therapy. Prostate Cancer Prostatic Dis 19(2):132CrossRef

Gul O, Eroglu M, Ozok U (2001) Use of terazosine in patients with chronic pelvic pain syndrome and evaluation by prostatitis symptom score index. Int Urol Nephrol 32(3):433–436CrossRef

10.

Cai T, Verze P, La Rocca R, Palmieri A, Tiscione D, Luciani LG, Mazzoli S, Mirone V, Malossini G (2017) The clinical efficacy of pollen extract and vitamins on chronic prostatitis/chronic pelvic pain syndrome is linked to a decrease in the pro-inflammatory cytokine interleukin-8. World J Mens Health 35(2):120–128CrossRef

11.

Tuğcu V, Taşçı Aİ, Fazlıoğlu A, Gürbüz G, Özbek E, Şahin S, Kurtuluş F, Çek M (2007) A placebo-controlled comparison of the efficiency of triple-and monotherapy in category III B chronic pelvic pain syndrome (CPPS). Eur Urol 51(4):1113–1118CrossRef

12.

Shoskes DA, Manickam K (2003) Herbal and complementary medicine in chronic prostatitis. World J Urol 21(2):109–113CrossRef

13.

Wagenlehner FM, Schneider H, Ludwig M, Schnitker J, Brähler E, Weidner W (2009) A pollen extract (Cernilton) in patients with inflammatory chronic prostatitis–chronic pelvic pain syndrome: a multicentre, randomised, prospective, double-blind, placebo-controlled phase 3 study. Eur Urol 56(3):544–551CrossRef

14.

Habib F, Ross M, Buck A, Ebeling L, Lewenstein A (1990) In vitro evaluation of the pollen extract cernitin T-60, in the regulation of prostate cell growth. Br J Urol 66(4):393–397CrossRef

15.

Morais M, Moreira L, Feás X, Estevinho LM (2011) Honeybee-collected pollen from five Portuguese Natural Parks: palynological origin, phenolic content, antioxidant properties and antimicrobial activity. Food Chem Toxicol 49(5):1096–1101CrossRef

16.

Maruyama H, Sakamoto T, Araki Y, Hara H (2010) Anti-inflammatory effect of bee pollen ethanol extract from Cistus sp. of Spanish on carrageenan-induced rat hind paw edema. BMC Complement Altern Med 10:30. https://doi.org/10.1186/1472-6882-10-30 CrossRefPubMedPubMedCentral

17.

Kamijo T, Sato S, Kitamura T (2001) Effect of cernitin pollen-extract on experimental nonbacterial prostatitis in rats. Prostate 49(2):122–131CrossRef

18.

Lesjak M, Beara I, Simin N, Pintać D, Majkić T, Bekvalac K, Orčić D, Mimica-Dukić N (2018) Antioxidant and anti-inflammatory activities of quercetin and its derivatives. J Funct Foods 40:68–75CrossRef

19.

Hashemzaei M, Delarami Far A, Yari A, Heravi RE, Tabrizian K, Taghdisi SM, Sadegh SE, Tsarouhas K, Kouretas D, Tzanakakis G et al (2017) Anticancer and apoptosis-inducing effects of quercetin in vitro and in vivo. Oncol Rep 38:819–828CrossRef

20.

Gardi C, Bauerova K, Stringa B, Kuncirova V, Slovak L, Ponist S, Drafi F, Bezakova L, Tedesco I, Acquaviva A (2015) Quercetin reduced inflammation and increased antioxidant defense in rat adjuvant arthritis. Arch Biochem Biophys 583:150–157CrossRef

21.

Shoskes DA, Zeitlin SI, Shahed A, Rajfer J (1999) Quercetin in men with category III chronic prostatitis: a preliminary prospective, double-blind, placebo-controlled trial. Urology 54(6):960–963CrossRef

22.

Meng LQ, Yang FY, Wang MS, Shi BK, Chen DX, Chen D, Zhou Q, He QB, Ma LX, Cheng WL (2018) Quercetin protects against chronic prostatitis in rat model through NF-κB and MAPK signaling pathways. Prostate 78(11):790–800CrossRef

23.

Procida G, Stancher B, Cateni F, Zacchigna M (2013) Chemical composition and functional characterisation of commercial pumpkin seed oil. J Sci Food Agric 93(5):1035–1041CrossRef

24.

Stevenson DG, Eller FJ, Wang L, Jane J-L, Wang T, Inglett GE (2007) Oil and tocopherol content and composition of pumpkin seed oil in 12 cultivars. J Agric Food Chem 55(10):4005–4013CrossRef

25.

Tsai Y-S, Tong Y-C, Cheng J-T, Lee C-H, Yang F-S, Lee H-Y (2006) Pumpkin seed oil and phytosterol-F can block testosterone/prazosin-induced prostate growth in rats. Urol Int 77(3):269–274CrossRef

26.

Ejike CE, Ezeanyika LU (2011) Inhibition of the experimental induction of benign prostatic hyperplasia: a possible role for fluted pumpkin (Telfairia occidentalis Hook f.) seeds. Urol Int 87(2):218–224CrossRef

27.

Tantawy SA, Elgohary HM, Kamel DM (2018) Trans-perineal pumpkin seed oil phonophoresis as an adjunctive treatment for chronic nonbacterial prostatitis. Res Rep Urol 10:95PubMedPubMedCentral

28.

Tagaya M, Oka M, Ueda M, Takagaki K, Tanaka M, Ohgi T, Yano J (2009) Eviprostat suppresses proinflammatory gene expression in the prostate of rats with partial bladder-outlet obstruction: a genome-wide DNA microarray analysis. Cytokine 47(3):185–193CrossRef

29.

Oka M, Ueda M, Oyama T, Kyotani J, Tanaka M (2009) Effect of the phytotherapeutic agent Eviprostat^® on 17β-estradiol-induced nonbacterial inflammation in the rat prostate. Prostate 69(13):1404–1410CrossRef

30.

Kawai Y, Oka M, Kyotani J, Oyama T, Matsumoto S, Kakizaki H (2013) Effect of the phytotherapeutic agent eviprostat on the bladder in a rat model of bladder overdistension/emptying. Neurourol Urodyn 32(7):1031–1037CrossRef

31.

Iwamura H, Koie T, Soma O, Matsumoto T, Imai A, Hatakeyama S, Yoneyama T, Hashimoto Y, Ohyama C (2015) Eviprostat has an identical effect compared to pollen extract (Cernilton) in patients with chronic prostatitis/chronic pelvic pain syndrome: a randomized, prospective study. BMC Urol 15(1):120CrossRef

32.

Tsunemori H, Sugimoto M, Xia Z, Taoka R, Oka M, Kakehi Y (2011) Effect of the phytotherapeutic agent Eviprostat on inflammatory changes and cytokine production in a rat model of nonbacterial prostatitis. Urology 77(6):1507.e1515–1507.e1520CrossRef

33.

Shibuya S, Xia Z, Sugimoto M, Ueda N, Haba R, Kakehi Y (2014) The phytotherapeutic agent, eviprostat, suppresses stromal proliferation and inflammation even after establishment of nonbacterial prostatitis in the rat prostate. Urology 83(3):528–534CrossRef

34.

Chua ME, Park JH, Castillo JC, Morales ML Jr (2013) Terpene compound drug as medical expulsive therapy for ureterolithiasis: a meta-analysis. Urolithiasis 41(2):143–151. https://doi.org/10.1007/s00240-012-0538-3 CrossRefPubMed

35.

Lee CB, Ha US, Lee SJ, Kim SW, Cho YH (2006) Preliminary experience with a terpene mixture versus ibuprofen for treatment of category III chronic prostatitis/chronic pelvic pain syndrome. World J Urol 24(1):55–60. https://doi.org/10.1007/s00345-005-0039-x CrossRefPubMed

36.

Wang S, Zhang D, Hu J, Jia Q, Xu W, Su D, Song H, Xu Z, Cui J, Zhou M, Yang J, Xiao J (2017) A clinical and mechanistic study of topical borneol-induced analgesia. EMBO Mol Med 9(6):802–815. https://doi.org/10.15252/emmm.201607300 CrossRefPubMedPubMedCentral

37.

Zhou JY, Tang FD, Mao GG, Bian RL (2004) Effect of alpha-pinene on nuclear translocation of NF-kappa B in THP-1 cells. Acta Pharmacol Sin 25(4):480–484PubMed

38.

Liu BP, Wang YT, Chen SD (2016) Effect of acupuncture on clinical symptoms and laboratory indicators for chronic prostatitis/chronic pelvic pain syndrome: a systematic review and meta-analysis. Int Urol Nephrol 48(12):1977–1991. https://doi.org/10.1007/s11255-016-1403-z CrossRefPubMed

39.

Qin Z, Zang Z, Zhou K, Wu J, Zhou J, Kwong JSW, Liu Z (2018) Acupuncture for chronic prostatitis/chronic pelvic pain syndrome: a randomized, sham acupuncture controlled trial. J Urol 200(4):815–822. https://doi.org/10.1016/j.juro.2018.05.001 CrossRefPubMed

40.

Sahin S, Bicer M, Eren GA, Tas S, Tugcu V, Tasci AI, Cek M (2015) Acupuncture relieves symptoms in chronic prostatitis/chronic pelvic pain syndrome: a randomized, sham-controlled trial. Prostate Cancer Prostatic Dis 18(3):249–254. https://doi.org/10.1038/pcan.2015.13 CrossRefPubMed

41.

Ohlsen BA (2013) Acupuncture and traditional chinese medicine for the management of a 35-year-old man with chronic prostatitis with chronic pelvic pain syndrome. J Chiropr Med 12(3):182–190. https://doi.org/10.1016/j.jcm.2013.10.004 CrossRefPubMedPubMedCentral

42.

Zhou M, Yang M, Chen L, Yu C, Zhang W, Ji J, Chen C, Shen X, Ying J (2017) The effectiveness of long-needle acupuncture at acupoints BL30 and BL35 for CP/CPPS: a randomized controlled pilot study. BMC Complement Altern Med 17(1):263. https://doi.org/10.1186/s12906-017-1768-2 CrossRefPubMedPubMedCentral

43.

Lee SW, Liong ML, Yuen KH, Krieger JN (2014) Acupuncture and immune function in chronic prostatitis/chronic pelvic pain syndrome: a randomized, controlled study. Complement Ther Med 22(6):965–969. https://doi.org/10.1016/j.ctim.2014.10.010 CrossRefPubMedPubMedCentral

44.

Schmitz C, Csaszar NB, Rompe JD, Chaves H, Furia JP (2013) Treatment of chronic plantar fasciopathy with extracorporeal shock waves (review). J Orthop Surg Res 8:31. https://doi.org/10.1186/1749-799X-8-31 CrossRefPubMedPubMedCentral

45.

Moretti B, Notarnicola A, Maggio G, Moretti L, Pascone M, Tafuri S, Patella V (2009) The management of neuropathic ulcers of the foot in diabetes by shock wave therapy. BMC Musculoskelet Disord 10:54. https://doi.org/10.1186/1471-2474-10-54 CrossRefPubMedPubMedCentral

46.

Vulpiani MC, Trischitta D, Trovato P, Vetrano M, Ferretti A (2009) Extracorporeal shockwave therapy (ESWT) in Achilles tendinopathy. A long-term follow-up observational study. J Sports Med Phys Fitness 49(2):171–176PubMed

47.

Salama AB, Abouelnaga WA (2018) Effect of radial shock wave on chronic pelvic pain syndrome/chronic prostatitis. J Phys Ther Sci 30(9):1145–1149. https://doi.org/10.1589/jpts.30.1145 CrossRefPubMedPubMedCentral

48.

Zimmermann R, Cumpanas A, Miclea F, Janetschek G (2009) Extracorporeal shock wave therapy for the treatment of chronic pelvic pain syndrome in males: a randomised, double-blind, placebo-controlled study. Eur Urol 56(3):418–424. https://doi.org/10.1016/j.eururo.2009.03.043 CrossRefPubMed

49.

Al Edwan GM, Muheilan MM, Atta ON (2017) Long term efficacy of extracorporeal shock wave therapy [ESWT] for treatment of refractory chronic abacterial prostatitis. Ann Med Surg (Lond) 14:12–17. https://doi.org/10.1016/j.amsu.2016.12.051 CrossRef

50.

Guu SJ, Geng JH, Chao IT, Lin HT, Lee YC, Juan YS, Liu CC, Wang CJ, Tsai CC (2018) Efficacy of low-intensity extracorporeal shock wave therapy on men with chronic pelvic pain syndrome refractory to 3-as therapy. Am J Mens Health 12(2):441–452. https://doi.org/10.1177/1557988317736585 CrossRefPubMed

51.

Vahdatpour B, Alizadeh F, Moayednia A, Emadi M, Khorami MH, Haghdani S (2013) Efficacy of extracorporeal shock wave therapy for the treatment of chronic pelvic pain syndrome: a randomized, controlled trial. ISRN Urol 2013:972601. https://doi.org/10.1155/2013/972601 CrossRefPubMedPubMedCentral

52.

Mariotto S, Cavalieri E, Amelio E, Ciampa AR, de Prati AC, Marlinghaus E, Russo S, Suzuki H (2005) Extracorporeal shock waves: from lithotripsy to anti-inflammatory action by NO production. Nitric Oxide 12(2):89–96. https://doi.org/10.1016/j.niox.2004.12.005 CrossRefPubMed

53.

Aghajanyan IG, Allen S (2016) Positive response to thermobalancing therapy enabled by therapeutic device in men with non-malignant prostate diseases: BPH and chronic prostatitis. Diseases. https://doi.org/10.3390/diseases4020018 CrossRefPubMedPubMedCentral

54.

Allen S (2017) The vascular factor plays the main role in the cause of pain in men with chronic prostatitis and chronic pelvic pain syndrome: the results of clinical trial on thermobalancing therapy. Diseases. https://doi.org/10.3390/diseases5040025 CrossRefPubMedPubMedCentral

55.

Jin JX, Wang HZ, Zhai ZX, Ma BL, Li QF, Xiao N, Wang ZP, Rodriguez R (2017) Transrectal microwave thermotherapy causing a short-time influence on sperm quality in Chinese chronic nonbacterial prostatitis patients. Asian J Androl 19(5):548–553. https://doi.org/10.4103/1008-682X.185852 CrossRefPubMed

56.

Gao M, Ding H, Zhong G, Lu J, Wang H, Li Q, Wang Z (2012) The effects of transrectal radiofrequency hyperthermia on patients with chronic prostatitis and the changes of MDA, NO, SOD, and Zn levels in pretreatment and posttreatment. Urology 79(2):391–396. https://doi.org/10.1016/j.urology.2011.08.046 CrossRefPubMed

57.

Allen S, Aghajanyan IG (2017) Efficacy of thermobalancing therapy for chronic prostatitis/chronic pelvic pain syndrome, confirmed by clinical study, may suggest etiology and pathophysiology of this disease. Can Urol Assoc J. https://doi.org/10.5489/cuaj.4473 CrossRefPubMedPubMedCentral

58.

Chiang PH, Chiang CP (2004) Therapeutic effect of transurethral needle ablation in non-bacterial prostatitis: chronic pelvic pain syndrome type IIIa. Int J Urol 11(2):97–102CrossRef

59.

Lee KC, Jung PB, Park HS, Whang JH, Lee JG (2002) Transurethral needle ablation for chronic nonbacterial prostatitis. BJU Int 89(3):226–229CrossRef

60.

Catley MJ, Gibson W, Wand BM, Meads C, O'Connell NE (2015) Transcutaneous Electrical Nerve Stimulation (TENS) for chronic pain ‐ an overview of Cochrane reviews. Cochrane Database Syst Rev 2:CD011890. https://doi.org/10.1002/14651858.CD011890 CrossRef

61.

Bennett MI, Johnson MI, Brown SR, Radford H, Brown JM, Searle RD (2010) Feasibility study of transcutaneous electrical nerve stimulation (TENS) for cancer bone pain. J Pain 11(4):351–359. https://doi.org/10.1016/j.jpain.2009.08.002 CrossRefPubMed

62.

Sikiru L, Shmaila H, Muhammed SA (2008) Transcutaneous electrical nerve stimulation (TENS) in the symptomatic management of chronic prostatitis/chronic pelvic pain syndrome: a placebo-control randomized trial. Int Braz J Urol 34(6):708–713 (discussion 714) CrossRef

63.

Schneider MP, Tellenbach M, Mordasini L, Thalmann GN, Kessler TM (2013) Refractory chronic pelvic pain syndrome in men: can transcutaneous electrical nerve stimulation help? BJU Int 112(2):E159–E163. https://doi.org/10.1111/bju.12005 CrossRefPubMed

64.

Kessler TM, Mordasini L, Weisstanner C, Juni P, da Costa BR, Wiest R, Thalmann GN (2014) Sono-electro-magnetic therapy for treating chronic pelvic pain syndrome in men: a randomized, placebo-controlled, double-blind trial. PLoS One 9(12):e113368. https://doi.org/10.1371/journal.pone.0113368 CrossRefPubMedPubMedCentral

Titel: Phytotherapy and physical therapy in the management of chronic prostatitis–chronic pelvic pain syndrome
verfasst von: Min Hu
Junaid Wazir
Rahat Ullah
Wenlu Wang
Xingxing Cui
Meng Tang
Xiaohui Zhou
Publikationsdatum: 03.05.2019
Verlag: Springer Netherlands
Erschienen in: International Urology and Nephrology / Ausgabe 7/2019
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI: https://doi.org/10.1007/s11255-019-02161-x

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Phytotherapy and physical therapy in the management of chronic prostatitis–chronic pelvic pain syndrome

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2019

Androgen deprivation therapy and the risk of tenosynovitis in prostate cancer patients

The relationship of blood neutrophil-to-lymphocyte ratio with nutrition markers and health outcomes in hemodialysis patients

Lactic acidosis due to metformin in type 2 diabetes mellitus and chronic kidney disease stage 3–5: is it significant?

Acute kidney injury in patients with HELLP syndrome

Theoretical and laboratory investigations of the effects of hydroxyproline ingestion on the metabolic and physicochemical risk factors for calcium oxalate kidney stone formation in a small group of healthy subjects

MR urethrography versus X-ray urethrography compared with operative findings for the evaluation of urethral strictures

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin